IP Library Patent Application 11890273
Patent Application
App. No. 11/890,273

Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/890,273
Abstract

A method and solution for local inhibition of pain and inflammation by application of a serotonin antagonist, and serotonin antagonist compositions for local delivery.

Claims (12)

1 . A method of treating a non-inflammatory local disease of the musculo-skeletal system selected from the group consisting of: a disease treated by arthroscopic surgery, a disease affecting a human body cavity or passage, an operative wound, a traumatic wound and any disease treated with an operative/interventional procedure in which irrigation can be performed in a subject in need thereof, which method comprises locally administering to said subject an effective amount of a 5-HT 3 receptor antagonist.

2 . A method according to claim 1 , wherein the 5-HT 3 receptor antagonist is administered locally at or near the site of the local disease, local irritation condition or local manifestation.

3 . The method of claim 1 , wherein the 5-HT 3 receptor antagonist is ondansetron.

4 . The method of claim 2 , wherein the 5-HT 3 receptor antagonist is ondansetron.

5 . The use of a 5-HT 3 receptor antagonist for the manufacture of a pharmaceutical composition for the treatment of local disease of the musculo-skeletal system selected from the group consisting of: a disease treated by arthroscopic surgery, a disease affecting a human body cavity or passage, an operative wound, a traumatic wound and any disease treated with an operative/interventional procedure in which irrigation can be performed.

6 . The use according to claim 5 , wherein the disease to be treated is a non-inflammatory local disease of the musculo-skeletal system selected from the group consisting of a disease treated by arthroscopic surgery, a disease affecting a human body cavity or passage, an operative wound, a traumatic wound, and any disease treated with an operative/interventional procedure in which irrigation can be performed.

7 . The use according to claim 5 , wherein the disease to be treated is a local disease of the musculo-skeletal system selected from the group consisting of a disease treated by arthroscopic surgery, a disease affecting a human body cavity or passage, an operative wound, a traumatic wound and any disease treated with an operative/interventional procedure in which irrigation can be performed.

8 . The use according to claim 5 , for the local treatment of a local manifestation at the locomotor apparatus of an inflammatory disease selected from the group consisting of a disease treated by arthroscopic surgery, a disease affecting a human body cavity or passage, an operative wound, a traumatic wound and any disease treated with an operative/interventional procedure in which irrigation can be performed.

9 . The use according to claim 5 , wherein the 5-HT 3 receptor antagonist is ondansetron.

10 . A method of treating a local disease of the musculo-skeletal system selected from the group consisting of a disease treated by arthroscopic surgery, a disease affecting a human body cavity or passage, an operative wound, a traumatic wound and any disease treated with an operative/interventional procedure in which irrigation can be performed, in a subject in need thereof, which method comprises locally administering to said subject an effective amount of 5-HT 3 receptor antagonist.

11 . A method according to claim 10 , wherein the 5-HT 3 receptor antagonist is administered locally at or near the site of the local disease, local irritation condition or local manifestation.

12 . A 5-HT 3 receptor antagonist or a pharmaceutical composition comprising a 5-HT 3 receptor antagonist for local use in the treatment of a local disease selected from the group consisting of a disease treated by arthroscopic surgery, a disease affecting a human body cavity or passage, an operative wound, a traumatic wound and any disease treated with an operative/interventional procedure in which irrigation can be performed.

Assignments (1)
SECURITY INTEREST Recorded Dec 2, 2024
From: SCIENTURE, LLC
To: ARENA FINANCE MARKETS, LP
Reel/Frame 069451/0170 →